HYPHENS PHARMA financial statements, including revenue, expenses, and profit

The total revenue of 1J5 for the last semiannual is 95.77 M SGD, and it's 3.89% lower compared to the previous semiannual. The net income of H2 24 is 4.78 M SGD.